发明申请
US20040033537A1 Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker
有权
使用总内源性乳铁蛋白作为标记来区分肠易激综合征与炎症性肠病（IBD）和IBD患者的方法
- 专利标题： Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker
- 专利标题（中）： 使用总内源性乳铁蛋白作为标记来区分肠易激综合征与炎症性肠病（IBD）和IBD患者的方法
-
申请号： US10629975申请日： 2003-07-30
-
公开(公告)号： US20040033537A1公开(公告)日： 2004-02-19
- 发明人: James Hunter Boone , David Maxwell Lyerly , Tracy Dale Wilkins , Richard Littleton Guerrant
- 申请人： TECHLAB, INC.
- 申请人地址： null
- 专利权人： TECHLAB, INC.
- 当前专利权人： TECHLAB, INC.
- 当前专利权人地址： null
- 主分类号： G01N033/53
- IPC分类号： G01N033/53
摘要：
A method for aiding in differentiating irritable bowel syndrome from inflammatory bowel disease by determining the level of total endogenous human lactoferrin in clinical specimens, such as feces, mucus and bile, wherein an elevated level of lactoferrin substantially precludes diagnoses of IBS and other noninflammatory etiologies, and a kit usable in such method are provided. Further provided is a method for quantitating the level of total endogenous human lactoferrin in clinical specimens, such as feces, mucus and bile, to monitor gastrointestinal inflammation in persons having inflammatory bowel disease.
公开/授权文献
信息查询
